Tuesday, November 30, 2021

  BENGALURU -- A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co's antiviral pill to treat COVID-19. The U.S. drugmaker published data last week suggesting that the drug was significantly less effective than previously thought, reducing hospitalizations and deaths in its clinical trial of high-risk individuals by around 30%. Still, medicines like Merck's molnupiravir, developed with Ridgeback Biotherapeutics, are likely to become important therapeutic tools that people will be able to take at home as soon as COVID-19 symptoms arise. A rival drug being developed by Pfizer Inc,...

Keep on reading: US FDA panel recommends agency authorize Merck’s COVID-19 drug
Sponsored Links : Snapchat Generator - Grab snapchat pass,photos,contacts and more for free.

Tiktok Booster - trends start here. Free Tiktok Followers, Likes, Views!

Resurge.com– The Resurge supplement is formulated to deliver fat-burning properties to help one lose weight in a short period.

0 comments:

Post a Comment

Search

Bookmark Us

Delicious Digg Facebook Favorites More Stumbleupon Twitter